Search results
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 1 day agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
What should you do if you’re still testing positive for COVID-19 after day 10?
The Today Show via AOL· 4 days agoBe on the lookout for cold- and flu-like symptoms, including sore throat, sneezing, congestion,...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe vaccine, dubbed mResvia, was developed to protect people age 60 and older from RSV. Usually, RSV...
Fewer people have symptoms after quitting antidepressants than previously thought
UPI· 1 day agoResearchers found that about a third (31%) of people who stopped taking an antidepressant...
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
WGRZ-TV Buffalo· 7 days agoGovernment officials still say the benefits of the shots outweigh the risks. Health officials have...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 3 days agoThe vaccine demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 6 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 6 days agoThe biotech received regulatory approval for its respiratory syncytial virus (RSV) vaccine, paving the way to commercialization of the product in time...
Why do I keep getting colds every few weeks? 4 reasons why
TODAY via Yahoo News· 4 days agoPay attention to what's circulating in your area to "get a sense for what you need to watch out...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 6 days agoIn a population of older adults, Arexvy reduced the risk of lower respiratory tract disease (LRTD)...
